ALISON SIMPSON: Open Payments
NPI 1306314026 · CHEYENNE, WY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$399 in 20 payments from 11 companies in 2025. Trend: 2023 $484 · 2024 $810 · 2025 $399
Food & beverage: $399
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $108 |
| Exact Sciences Corporation | 3 | $63 |
| Novo Nordisk Inc | 2 | $44 |
| Amgen Inc. | 2 | $37 |
| Lundbeck LLC | 1 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $27 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| SANOFI-AVENTIS U.S. LLC | 1 | $18 |
| Phadia US Inc. | 1 | $17 |
Products named: BREZTRI, Cologuard Collection Kit, Wegovy, REXULTI, CAPLYTA, REPATHA, INSPIRE, SHINGRIX.
Industry payments across WY — which companies pay providers there.
